Avid Bioservices Receives Five 2020 CMO Leadership Awards
March 26 2020 - 08:05AM
Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated
biologics contract development and manufacturing organization
(CDMO) working to improve patient lives by providing high quality
development and manufacturing services to biotechnology and
pharmaceutical companies, today announced that the company has been
named a recipient of five 2020 Contract Manufacturing Organization
(CMO) Leadership Awards. Presented by the industry
publication Life Science Leader and based on market research and
surveys conducted by Industry Standard Research (ISR), these awards
are intended to honor those companies in the contract manufacturing
space that provide their customers with the industry’s highest
level of service.
Avid received awards in the following
categories:
- Capabilities
- Expertise
- Reliability
- Compatibility
- Service
Additionally, the company was named a 2020 CMO
Leadership Award Champion in the categories of expertise and
service. Top performing companies are recognized as Champions
if they scored a one-half standard deviation or more above the
weighted average in a specific category.
“Avid is honored to be recognized by the CMO
Leadership Awards, particularly by our designation as a Champion in
the expertise and service categories. The CMO Leadership
Awards are among the most meaningful in our industry as the winners
are selected, in part, based on feedback from CDMO industry
customers. As a company whose entire business philosophy is
built upon the concept of doing whatever it takes to deliver for
our customers, this recognition is truly gratifying,”
said Rick Hancock, interim president and chief executive
officer of Avid. “The excellence required to be recognized by
our customers and the broader CDMO industry is a collective effort
and we thank each and every member of the Avid team for their
important contributions to the company’s success.”
Life Science Leader’s CMO Leadership Awards aim
to provide industry insiders with accurate and reliable customer
feedback to assist them in choosing a reputable partner for their
development and manufacturing needs. For more information about
Life Science Leader’s CMO Leadership Awards, please visit:
http://cmoleadershipawards.com/.
About Avid
Bioservices, Inc.
Avid Bioservices is a dedicated contract
development and manufacturing organization (CDMO) focused on
development and CGMP manufacturing of biopharmaceutical products
derived from mammalian cell culture. The company provides a
comprehensive range of process development, high quality CGMP
clinical and commercial manufacturing services for the
biotechnology and biopharmaceutical industries. With over 25 years
of experience producing monoclonal antibodies and recombinant
proteins in batch, fed-batch and perfusion modes, Avid's services
include CGMP clinical and commercial product manufacturing,
purification, bulk packaging, stability testing and regulatory
strategy, submission and support. The company also provides a
variety of process development activities, including cell line
development and optimization, cell culture and feed optimization,
analytical methods development and product
characterization. www.avidbio.com
Contacts:
Stephanie Diaz (Investors)
Vida Strategic Partners
415-675-7401
sdiaz@vidasp.com
Tim Brons (Media)
Vida Strategic Partners
415-675-7402
tbrons@vidasp.com
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Feb 2024 to Mar 2024
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Mar 2023 to Mar 2024